Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/1fda33bb-846a-4e57-82ce-99a6d160480d/

B72

AtaiBeckley Inc.
Chart
6.25 EUR
Latest Week 2026-07-24
HealthcareBiotechnologyMID
Snapshot 2026-07-26 · 0.7w · Fresh
0.68
OS Score
56.0%
Value
54.0%
Quality
56.0%
Momentum
3/9
F-Score
0.550
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
56.0%ile
P/S
662.9×
P/B
11.6×
FCF Yield
-0.049
SH Yield
-0.083
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
45.00000000
/100 — 1=cheapest
VC2 (Trending Value)
47.00000000
/100
VC3 (Buyback)
46.00000000
/100
Negative FCF yield (-4.9%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
54.0%ile
ROE
-3.339
ROA
-2.505
Net Margin
-190.194
Op Margin
-35.311
Current
10.02
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Stability
1.652
lower=better
Accruals
-2.105
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
56.0%ile
6M Return
82.4%
12M Return
107.9%
12-1 Mom
27.7%
Risk-Adj
0.38
Vol 252d
73.5%
Vol 60d
167.9%
↑ Expanding
Max DD 12M
-41.4%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 28% is very strong — a clear uptrend. Near-term vol (168%) is expanding vs long-term (73%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.68
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 77 peers
Sector Value %ile
67.9%
Sector Quality %ile
38.5%
P/B z-score
1.50
Sector Avg OS
49.6%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
MED MEDICLIN Aktiengesellschaft 99.0% 97.0% 82.0% 82.0%
NOV Novo Nordisk A/S 96.0% 98.0% 83.0% 39.0%
M12 M1 Kliniken AG 96.0% 77.0% 92.0% 73.0%
DRW8 Drägerwerk AG & Co. KGaA 96.0% 93.0% 58.0% 79.0%
CBHD Coloplast A/S 95.0% 98.0% 92.0% 27.0%
DRW3 Drägerwerk AG & Co. KGaA 94.0% 85.0% 58.0% 78.0%
DMP Dermapharm Holding SE 94.0% 71.0% 93.0% 70.0%
NN6 NanoRepro AG 93.0% 75.0% 70.0% 80.0%
Factor Interactions
Volatility Expanding
60-day vol (168%) significantly exceeds 252-day (73%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
0.0% avg (4 factors)
Quality
D
33.3% avg (6 factors)
Momentum
A
76.2% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.680—0—
Value %ile0.560—0—
Quality %ile0.540—0—
Momentum %ile0.560—0—
F-Score3.000—8—
Confidence0.696—0—
Volatility0.735—8—
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
662.91
Price / Book
11.64
FCF Yield
-4.9%
Sales Yield (1/P·S)
0.0015
Shareholder Yield
Div + net buyback / mktcap
-8.3%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-333.9%
Return on Assets
-250.5%
Net Margin
-19019.4%
Operating Margin
-3531.1%
Current Ratio
10.02
Accruals Ratio
(NI-OCF)/Assets — lower=better
-2.105
External Financing
Net issuance — lower=better
0.774
MomentumPrice trend strength over different horizons
6M Return
82.4%
12M Return
107.9%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
27.7%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.38
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Earnings Stability (CV)
Lower = more stable
1.652
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
3
Buyback Yield
-8.3%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
45
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
47
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
46
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity